Epigenetic alterations leading to TMPRSS4 promoter hypomethylation and protein overexpression predict poor prognosis in squamous lung cancer patients

Filiacions

Villalba M:

Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Navarra, Spain

IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain

Diaz-Lagares A:

Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Catalonia, Spain

Redrado M:

IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain

de Aberasturi AL:

Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Navarra, Spain

IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain

Segura V:

IDISNA and Bioinformatics Unit, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain

Bodegas ME:

Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Navarra, Spain

Pajares MJ:

Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Navarra, Spain

IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain

Pio R:

IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain

Department of Biochemistry and Genetics, School of Sciences, University of Navarra, Pamplona, Navarra, Spain

Freire J:

Department of Pathology, University Hospital Marques de Valdecilla, IDIVAL, Santander, Spain

Gomez-Roman J:

Department of Pathology, University Hospital Marques de Valdecilla, IDIVAL, Santander, Spain

Montuenga LM:

Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Navarra, Spain

IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain

Esteller M:

Cancer Epigenetics and Biology Program (PEBC), Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet, Catalonia, Spain

Sandoval J:

Instituto de Investigación. Department of Personalized Medicine, Epigenomics Unit, Medical Research Institute La Fe, Valencia, Spain

Calvo A:

Department of Histology and Pathology, School of Medicine, University of Navarra, Pamplona, Navarra, Spain

IDISNA and Program in Solid Tumors and Biomarkers, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Navarra, Spain